Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Early-onset male baldness may increase the risk of metabolic syndrome.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

The document concludes that computational methods using networks and various data can improve the process of finding new uses for existing drugs.

The document concludes that understanding health requires considering evolutionary perspectives on reproductive fitness, and recognizing the complexity of factors like diet, testosterone, and sexual orientation.

Not getting enough minerals can lead to health problems and shorter lifespans.

Oxidative stress worsens PCOS by damaging cells and disrupting metabolism, suggesting antioxidant treatments might help.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

High YKL-40 levels predict early hair loss and hidden metabolic issues.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Finasteride and dutasteride may cause metabolic issues like liver disease and diabetes.

Vitamin D is important for bones, hair, blood pressure, and breast development.

Mice with LSS deficiency showed hair loss and cataracts, similar to humans, and can help in understanding and treating this condition.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Hair follicle stem cells and mitochondria are key for hair growth, and targeting their activity could lead to new hair loss treatments.

Human umbilical cord stem cell vesicles may help treat aging and related diseases.

Lower LDL-c levels predict higher COVID-19 mortality.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.